Adipocyte Fatty Acid–Binding Protein Is a Plasma Biomarker Closely Associated with Obesity and Metabolic Syndrome | Zendy

Aimin Xu | Zendy; Yu Wang | Zendy; Jian Xu | Zendy; David Stejskal | Zendy; Sidney Tam | Zendy; Jialiang Zhang | Zendy; Nelson M.S. Wat | Zendy; Wai Keung Wong | Zendy; Karen SL Lam | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Adipocyte Fatty Acid–Binding Protein Is a Plasma Biomarker Closely Associated with Obesity and Metabolic Syndrome

Author(s) -

Aimin Xu,

Yu Wang,

Jian Xu,

David Stejskal,

Sidney Tam,

Jialiang Zhang,

Nelson M.S. Wat,

Wai Keung Wong,

Karen SL Lam

Publication year - 2006

Publication title -

clinical chemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.705

H-Index - 218

eISSN - 1530-8561

pISSN - 0009-9147

DOI - 10.1373/clinchem.2005.062463

Subject(s) - medicine , endocrinology , insulin resistance , metabolic syndrome , body mass index , obesity , biomarker , fatty acid binding protein , dyslipidemia , overweight , waist , adipocyte , biology , adipose tissue , biochemistry , gene

Adipocyte fatty acid-binding protein (A-FABP) is traditionally thought to be a cytosolic fatty acid chaperone expressed in adipocytes. Mice with targeted disruption of the A-FABP gene exhibit a striking phenotype with strong protection from insulin resistance, hyperglycemia, and atherosclerosis. The clinical relevance of these findings remains to be confirmed.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research